These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8197884)

  • 1. The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart.
    Fazekas T; Scherlag BJ; Mabo P; Berlin KD; Garrison GL; Chen CL; Sangiah S; Patterson E; Lazzara R
    Acta Physiol Hung; 1993; 81(3):289-99. PubMed ID: 8197884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Am Heart J; 1994 Feb; 127(2):345-52. PubMed ID: 7507635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat.
    Pugsley MK; Saint DA; Hayes E; Berlin KD; Walker MJ
    Eur J Pharmacol; 1995 Dec; 294(1):319-27. PubMed ID: 8788447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force.
    Chen CL; Sangiah S; Patterson E; Berlin KD; Garrison GL; Dunn W; Nan Y; Scherlag BJ; Lazzara R
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):3-16. PubMed ID: 1334277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
    Krejcy K; Krumpl G; Todt H; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperchlorate.
    Garrison GL; Berlin KD; Scherlag BJ; Lazzara R; Patterson E; Fazekas T; Sangiah S; Chen CL; Schubot FD; van der Helm D
    J Med Chem; 1996 Jun; 39(13):2559-70. PubMed ID: 8691454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, conformational analysis, and antiarrhythmic properties of 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonan-9-one, 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonane hydroperchlorate, and 7-benzyl-9-phenyl-3-thia-7-azabicyclo[3.3.1]nonan-9-ol hydroperchlorate and derivatives: single-crystal X-ray diffraction analysis and evidence for chair-chair and chair-boat conformers in the solid state.
    Bailey BR; Berlin KD; Holt EM; Scherlag BJ; Lazzara R; Brachmann J; van der Helm D; Powell DR; Pantaleo NS; Ruenitz PC
    J Med Chem; 1984 Jun; 27(6):758-67. PubMed ID: 6737418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
    Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
    Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of lidocaine on reentrant ventricular rhythms in the subacute myocardial infarction period in dogs.
    Yin H; el-Sherif N; Caref EB; Ndrepepa G; Levin R; Isber N; Stergiopolus K; Assadi MA; Gough WB; Restivo M
    Am J Physiol; 1997 Jan; 272(1 Pt 2):H299-309. PubMed ID: 9038950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
    Wallace AA; Stupienski RF; Kothstein T; Gehret JR; Lynch JJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):397-404. PubMed ID: 7681500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.